These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 196800

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Serum antibody profile against herpesviruses in renal transplant recipients.
    Carpi C, Donati M, Musiani M, Zerbini M, Cevenini R, Feletti C.
    Boll Ist Sieroter Milan; 1982; 61(3):245-7. PubMed ID: 6100358
    [Abstract] [Full Text] [Related]

  • 26. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
    Milbradt H, Flik J, Stangel W, Heigel R.
    Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
    [Abstract] [Full Text] [Related]

  • 27. Studies of cytomegalovirus infection in renal allograft recipients. II. Serological response to various viral antigens.
    Gadler H, Sundqvist V, Tillegård A, Wahren B.
    Scand J Infect Dis; 1982; 14(2):89-94. PubMed ID: 6285452
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.
    Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM.
    N Engl J Med; 1992 Apr 30; 326(18):1182-6. PubMed ID: 1313549
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients.
    Chatterjee SN, Fiala M, Weiner J, Stewart JA, Stacey B, Warmer N.
    JAMA; 1978 Nov 24; 240(22):2446-9. PubMed ID: 213620
    [Abstract] [Full Text] [Related]

  • 35. Detection of antibody to cytomegalovirus early antigen in vaccinated, normal volunteers and renal transplant candidates.
    Friedman AD, Furukawa T, Plotkin SA.
    J Infect Dis; 1982 Aug 24; 146(2):255-9. PubMed ID: 6286789
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation.
    Rubin RH, Tolkoff-Rubin NE, Oliver D, Rota TR, Hamilton J, Betts RF, Pass RF, Hillis W, Szmuness W, Farrell ML.
    Transplantation; 1985 Sep 24; 40(3):243-9. PubMed ID: 2994266
    [Abstract] [Full Text] [Related]

  • 38. Cytomegalovirus infection and immunity in renal allograft recipients: assessment of the competence of humoral immunity.
    Rytel MW, Balay J.
    Infect Immun; 1976 Jun 24; 13(6):1633-7. PubMed ID: 184042
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.